Entries by Rebecca Mercer

Abstract submission for #ARCC2025 @ CCRC2025 is NOW OPEN!

As a reminder, #ARCC2025 is officially a part of the 2025 Canadian Cancer Research Conference. Abstracts are now being accepted for this important event which is being held in Calgary on November 2-4, 2025. Find out more at https://cc-arcc.ca/arcc-conference-2025/ and https://www.ccra-acrc.ca/conference/ The conference will feature plenary, concurrent, and lightning sessions, (more…)

CPAC – Lead, Forecasting and Modelling

The Lead, Forecasting and Modelling supports the Cancer Systems and Innovation Division in carrying out projects and initiatives to achieve the Partnership’s overall vision to reduce the burden of cancer on all people in Canada. Reporting to the Manager, Decision Support, and working closely with key experts, the incumbent provides content-specific expertise (more…)

Ontario Cancer Statistics 2024

Ontario Cancer Statistics 2024 is now available. It is the fifth in a series of reports that provide comprehensive information on the burden of cancer in the province. This edition continues to provide a snapshot of the burden of childhood cancers (ages 0 to 14) through the contribution of the Pediatric (more…)

UofT RWE Bootcamp – Registration is open

Course Overview For full details and to register please visit https://www.pharmacy.utoronto.ca/programs/continuing-professional-development/RWE-Bootcamp  Explore Real World Evidence (RWE) in a 3-day program designed by experts and tailored for professionals seeking to enter or enhance their knowledge in this field. This program is set at a beginner or novice level. We will cover (more…)

2025 CCTG Recognition Awards

The Canadian Cancer Trials Group is seeking nominations for the 2025 Recognition Awards honouring individuals who have contributed significantly to the mission and activities of the Group. CCTG is seeking nominations for the following Recognition Awards: Founder’s Award: Dr. Joseph Pater Excellence in Clinical Trials Research The Founder’s Award is (more…)